ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617581 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617581; 2) Community: the network communities that were significantly associated with the response to NSC 617581; 3) Molecule: the relationships between components within communities and NSC 617581; 4) MDR: the compounds that were significantly associated with the NSC 617581.

NSC Compound Enrichment Correlation
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.0388857481216096 0.34534481
NSC 683247 Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride 0.0388857481216096 0.2570252
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.0388857481216096 0.14177704
NSC 687011 stereoisomer of 672120 (MW=262) 0.0388857481216096 0.34209802
NSC 694234 Null 0.0388857481216096 -0.14278555
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.0388857481216096 0.40954478
NSC 763587 Null 0.0388857481216096 0.40362123
NSC 174121 Methotrexate Derivative 0.03888574812161 0.2061126
NSC 285166 Oxine 0.03888574812161 0.44037563
NSC 602066 1-Penten-3-one, 1,1'-(1,4-phenylene)bis[5-(diethylamino)- 4,4-dimethyl-, dihydrobromide 0.03888574812161 0.42829671
Total:77  Current:55    [First] [Prev] [Next] [Last]